Robert Kramer - Feb 23, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 23, 2023
Transactions value $
-$42,233
Form type
4
Date filed
2/27/2023, 07:22 PM
Previous filing
Feb 10, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$20.4K -1.43K -1.3% $14.30 108K Feb 23, 2023 Direct F1
transaction EBS Common Stock Tax liability -$21.8K -1.59K -1.47% $13.71 107K Feb 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.